Melina Arazy

455 total citations
2 papers, 37 citations indexed

About

Melina Arazy is a scholar working on Hematology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Melina Arazy has authored 2 papers receiving a total of 37 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Hematology, 1 paper in Infectious Diseases and 1 paper in Molecular Biology. Recurrent topics in Melina Arazy's work include Multiple Myeloma Research and Treatments (2 papers), Acute Myeloid Leukemia Research (1 paper) and Protein Degradation and Inhibitors (1 paper). Melina Arazy is often cited by papers focused on Multiple Myeloma Research and Treatments (2 papers), Acute Myeloid Leukemia Research (1 paper) and Protein Degradation and Inhibitors (1 paper). Melina Arazy collaborates with scholars based in United States, Canada and Poland. Melina Arazy's co-authors include Nizar J. Bahlis, Heather J. Sutherland, Darrell White, Michaël Sébag, Maryana Simonova, Sosana Delimpasi, Ivan Špıčka, Adriana Rossi, Gary J. Schiller and Rami Kotb and has published in prestigious journals such as Journal of Clinical Oncology.

In The Last Decade

Melina Arazy

2 papers receiving 37 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melina Arazy United States	2	36	32	22	4	3	2	37
Cristina Nevado García Spain	3	25 0.7×	21 0.7×	16 0.7×	4 1.0×	2 0.7×	8	35
Maryana Simonova Greece	3	28 0.8×	23 0.7×	15 0.7×	6 1.5×	2 0.7×	4	29
Edvan Crusoé Brazil	2	28 0.8×	18 0.6×	15 0.7×	8 2.0×	2 0.7×	4	29
Hans‐Walter Lindemann Germany	2	39 1.1×	19 0.6×	11 0.5×	7 1.8×	2 0.7×	3	45
Debbie Hastings United States	3	21 0.6×	20 0.6×	13 0.6×	7 1.8×	3 1.0×	7	30
Brianna Berrios United States	3	26 0.7×	21 0.7×	15 0.7×	4 1.0×	1 0.3×	4	37
Olga Shvetz Israel	3	22 0.6×	19 0.6×	16 0.7×	4 1.0×		6	26
Martina Emde Germany	3	32 0.9×	39 1.2×	24 1.1×	15 3.8×	2 0.7×	6	49
Edward A. Belter United States	3	17 0.5×	25 0.8×	9 0.4×	2 0.5×	2 0.7×	3	39
Carolina Lonardi United States	3	23 0.6×	20 0.6×	28 1.3×	4 1.0×		14	36

Countries citing papers authored by Melina Arazy

Since Specialization

Citations

This map shows the geographic impact of Melina Arazy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melina Arazy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melina Arazy more than expected).

Fields of papers citing papers by Melina Arazy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melina Arazy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melina Arazy. The network helps show where Melina Arazy may publish in the future.

Co-authorship network of co-authors of Melina Arazy

This figure shows the co-authorship network connecting the top 25 collaborators of Melina Arazy. A scholar is included among the top collaborators of Melina Arazy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melina Arazy. Melina Arazy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Gasparetto, Cristina, Suzanne Lentzsch, Gary J. Schiller, et al.. (2020). Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).. Journal of Clinical Oncology. 38(15_suppl). 8510–8510. 15 indexed citations

2.

Dimopoulos, Meletios Α., Sosana Delimpasi, Maryana Simonova, et al.. (2020). Weekly selinexor, bortezomib, and dexamethasone (SVd) versus twice weekly bortezomib and dexamethasone (Vd) in patients with multiple myeloma (MM) after one to three prior therapies: Initial results of the phase III BOSTON study.. Journal of Clinical Oncology. 38(15_suppl). 8501–8501. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact